Skip to main content

Advertisement

SpringerLink
Log in

The current managements of pancreatic diabetes in Japan

  • Clinical Review
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Pancreatic diabetes is secondary diabetes followed by progressions of pancreatic exocrine diseases, such as chronic pancreatitis, pancreatic neoplasm and post-pancreatectomy. Because of destruction and reduction of the pancreatic endocrine and exocrine functional compartments, patients with pancreatic diabetes frequently show malnutrition from maldigestion and malabsorption by insufficiencies in pancreatic digestive enzymes, and show unstable glycemic control and prolonged hypoglycemia by insufficiencies in synthesis and secretion of insulin and glucagon. Epidemiological studies have suggested that the incidence and development of pancreatic diabetes in patients with chronic pancreatitis (CP) depends on several risk factors, such as alcohol intake, the presence of pancreatic calcification and the long-term duration of CP. The clinical management of pancreatic diabetes is divided into two parts: one is the supplementation of pancreatic digestive enzymes and the other is the achievement of appropriate glycemic control. The appropriate and sufficient pancreatic exocrine replacement therapy is important for the maintenance of better nutrient conditions for patients with pancreatic diabetes. Furthermore, the intensive insulin therapy combined with short- or ultra-short-acting insulin and long-acting insulin glargine can be achieved for stable glycemic control and reduction of severe frequent hypoglycemia in patients with pancreatic diabetes. These current advanced management techniques against insufficiencies of pancreatic exocrine endocrine functions are beneficial for improving and maintaining the quality of life in patients with pancreatic diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Owyang C. Endocrine changes in pancreatic insufficiency. In: Go VLW, DiMagno EP, editors. The pancreas: biology, pathobiology and disease. New York: Raven; 1993. p. 803–13.

    Google Scholar 

  2. Koizumi M, Yoshida Y, Abe N, Shimosegawa T, Toyota T. Pancreatic diabetes in Japan. Pancreas. 1998;16:385–91.

    Article  CAS  PubMed  Google Scholar 

  3. Angelopoulos N, Dervenis C, Goula A, Rombopoulos G, Livadas S, Kaltsas D, et al. Endocrine pancreatic insufficiency in chronic pancreatitis. Pancreatology. 2005;5:122–31.

    Article  PubMed  Google Scholar 

  4. Ito T, Otsuki M, Itoi T, Shimosegawa T, Funakoshi A, Shiratori K, et al. Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan. J Gastroenterol. 2007;42:291–7.

    Article  PubMed  Google Scholar 

  5. Kuzuya T, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, et al. Report of the Committee on the classification and diagnosis criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85.

    Article  PubMed  Google Scholar 

  6. Sjoberg RJ, Kidd GS. Pancreatic diabetes mellitus. Diabetes Care. 1989;12:715–24.

    Article  CAS  PubMed  Google Scholar 

  7. Larsen S. DM secondary to chronic pancreatitis. Dan Med Bull. 1993;40:153–62.

    CAS  PubMed  Google Scholar 

  8. Miyahara T, Kawabuchi M, Goto M, Nakano I, Nada O, Nawata H. Morphological study of pancreatic endocrine in an experimental chronic pancreatitis with diabetes induced by stress and cerulein. Ultrastruct Pathol. 1999;23:171–80.

    Article  CAS  PubMed  Google Scholar 

  9. Maartense S, Ledeboer M, Masclee AA. Chronic pancreatitis: relation between function and morphology. Dig Liver Dis. 2004;36:61–7.

    Article  CAS  PubMed  Google Scholar 

  10. Goto M, Nakano I, Kimura T, Miyahara T, Kinjo M, Nawata H. New chronic pancreatitis model with diabetes induced by cerulein plus stress in rats. Dig Dis Sci. 1995;40:2356–63.

    Article  CAS  PubMed  Google Scholar 

  11. Cavallini G, Vaona B, Bovo P, Cigolini M, Rigo L, Rossi F, et al. Diabetes in chronic alcholic pancreatitis Role of residual beta cell function and insulin resistance. Dig Dis Sci. 1993;38:497–501.

    Article  CAS  PubMed  Google Scholar 

  12. Sarles H, Sarles JC, Camatte R, Muratore R, Gaini M, Guien C, et al. Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut. 1965;6:545–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Bank S, Marks IN, Vinik AI. Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol. 1975;64:13–22.

    CAS  PubMed  Google Scholar 

  14. Stone VW, Sarr MG, Nagorney DM, Mcllrath DC. Chronic pancreatitis results of Whipple’s resection and total pancreatectomy. Arch Surg. 1988;123:815–9.

    Article  CAS  PubMed  Google Scholar 

  15. Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol. 2004;18:947–55.

    Article  PubMed  Google Scholar 

  16. Nakamura T, Imamura K, Takebe K, Terada A, Arai Y, Tandoh Y, et al. Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis. Int J Pancreatol. 1996;20:169–75.

    Article  CAS  PubMed  Google Scholar 

  17. Malka D, Hammel P, Sauvanet A, Rufat P, O’Toole D, Bardet P, et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology. 2000;119:1324–32.

    Article  CAS  PubMed  Google Scholar 

  18. Owens DR, Jones IR, Birtwell AJ, Burge CTR, Davies CJ, Heyburn P, et al. Study of porcine and human isophane (NPH) insulins in normal subjects. Diabetologia. 1984;26:261–5.

    Article  CAS  PubMed  Google Scholar 

  19. Peters A, Klose O, Hefty R, Keck F, Kerner W. The influence of insulin antibodies on the pharmacokinetics of NPH insulin in patients with type 1 diabetes treated with human insulin. Diabet Med. 1995;12:925–30.

    Article  CAS  PubMed  Google Scholar 

  20. Pieber TR, Eugene-Jolchine I, Derobert E. The European Study Group of HOE 901 in Type1 Diabetes. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. Diabetes Care. 2000;23:157–62.

    Article  CAS  PubMed  Google Scholar 

  21. Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. The U.S. Study Group of Insulin Glargine in Type 1 Diabetes Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care. 2000;23:639–43.

    Article  CAS  PubMed  Google Scholar 

  22. Riddle MC, Rosenstock J, Gerich J. The Insulin Glargine 4002 Study Investigators Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080–6.

    Article  CAS  PubMed  Google Scholar 

  23. Yki-Jarvinen H, Dressler A, Ziemen M. The HOE 901/3002 Study Group Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care. 2000;23:1130–6.

    Article  CAS  PubMed  Google Scholar 

  24. Porcellati F, Rossetti P, Busciantella NR, Lucidi P, Luzio S, Owens DR, et al. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes A double-blind Randomized, crossover study. Diabetes Care. 2007;30:2447–52.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Research Committee if Intractable Pancreatic Diseases, provided by the Ministry of Health, Labor, and Welfare, Japan. The authors thank S.E. Rife and H. Matsuo for their contributions to this article.

Author information

Authors and Affiliations

  1. Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, 812-8582, Japan

    Ken Kawabe, Tetsuhide Ito, Hisato Igarashi & Ryoichi Takayanagi

Authors
  1. Ken Kawabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsuhide Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hisato Igarashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryoichi Takayanagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tetsuhide Ito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawabe, K., Ito, T., Igarashi, H. et al. The current managements of pancreatic diabetes in Japan. Clin J Gastroenterol 2, 1–8 (2009). https://doi.org/10.1007/s12328-008-0052-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-008-0052-x

Keywords

Search

Navigation